Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells

Oncogene

Volumn 31, Issue 11, 2012, Pages 1468-1474

  Jennewein, C ^a   Karl, S ^a   Baumann, B ^b   Micheau, O ^c   Debatin, K M ^a   Fulda, S ^a,d  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c boulevard Jeanne d'Arc   (France)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

apoptosis; CD95; glioblastoma; NF B; TRAIL

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR 4; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P43; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BRAIN TUMOR; CELL LINE; COMPARATIVE STUDY; DNA BINDING; DNA DAMAGE; GLIOBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BRAIN NEOPLASMS; CASPASES; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; MICE; NF-KAPPA B; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTIONAL ACTIVATION;

EID: 84858337114     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.333     Document Type: Article

References (23)

1. Ammann JU, Haag C, Kasperczyk H, Debatin KM, Fulda S. (2009). Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-kappaB inhibition. Int J Cancer 124: 1301-1311.
2. Campbell KJ, Rocha S, Perkins ND. (2004). Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13: 853-865.
3. DeAngelis LM. (2001). Brain tumors. N Engl J Med 344: 114-123.
4. Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ et al. (1999). Absence of tumor necrosis factor rescues RelAdeficient mice from embryonic lethality. Proc Natl Acad Sci USA 96: 2994-2999.
5. Farhana L, Dawson MI, Fontana JA. (2005). Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation. Cancer Res 65: 4909-4917.
6. Fulda S, Debatin KM. (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-4811.
7. Furnari FB, Fenton T, Bachoo RM,Mukasa A, Stommel JM, Stegh A et al. (2007). Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710.
8. Humphreys RC, Halpern W. (2008). Trail receptors: Targets for cancer therapy. Adv Exp Med Biol 615: 127-158.
9. Kang S, Park SY, Lee HJ, Yoo YH. (2010). TRAIL upregulates decoy receptor 1 and mediates resistance to apoptosis in insulin-secreting INS-1 cells. Biochem Biophys Res Commun 396: 731-735.
10. Karin M, Cao Y, Greten FR, Li ZW. (2002). NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2: 301-310.
11. Karl S, Pritschow Y, Volcic M, Hacker S, Baumann B, Wiesmuller L et al. (2009). Identification of a novel pro-Apopotic function of NFkappaB in the DNA damage response. J CellMolMed 13: 4239-4256.
12. Kohlhaas SL, Craxton A, Sun XM, Pinkoski MJ, Cohen GM. (2007). Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J Biol Chem 282: 12831-12841.
13. Mader I, Wabitsch M, Debatin KM, Fischer-Posovszky P, Fulda S. (2010). Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis. Faseb J 24: 1997-2009.
14. Mattson MP. (2005). NF-kappaB in the survival and plasticity of neurons. Neurochem Res 30: 883-893.
15. Micheau O, Tschopp J. (2003). Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190.
16. Pennarun B, Meijer A, de Vries EG, Kleibeuker JH, Kruyt F, de Jong S. (2010). Playing the DISC: Turning on TRAIL death receptor-mediated apoptosis in cancer. Biochim Biophys Acta 1805: 123-140.
17. Plantivaux A, Szegezdi E, Samali A, Egan L. (2009). Is there a role for nuclear factor kappaB in tumor necrosis factor-related apoptosisinducing ligand resistance? Ann NY Acad Sci 1171: 38-49.
18. Poppelmann B, Klimmek K, Strozyk E, Voss R, Schwarz T, Kulms D. (2005). NF{kappa}B-dependent down-regulation of tumor necrosis factor receptor-Associated proteins contributes to inte. J Biol Chem 280: 15635-15643.
19. Radhakrishnan SK, Kamalakaran S. (2006). Pro-Apoptotic role of NF-kappa B: Implications for cancer therapy. Biochim Biophys Acta 1766: 53-62.
20. Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gelinas C et al. (2001). Regulation of death receptor expression and TRAIL/ Apo2L-induced apoptosis by NF-kappaB. Nat Cell Biol 3: 409-416.
21. Shou Y, Li N, Li L, Borowitz JL, Isom GE. (2002). NF-kappaBmediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis. J Neurochem 81: 842-852.
22. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W et al. (1989). Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305.
23. Zhao X, Laver T, Hong SW, Twitty Jr GB, Devos A, Devos M et al. (2011). An NF-kappaB p65-cIAP2 link is necessary for mediating resistance to TNF-Alpha induced cell death in gliomas. J Neurooncol 102: 367-381.